Monday, October 26, 2020 7:53:32 AM
https://www.businesswire.com/news/home/20201026005289/en/Spectrum-Pharmaceuticals-Announces-that-the-FDA-is-Deferring-its-Action-on-the-BLA-for-ROLONTIS%C2%AE-eflapegrastim/?feedref=Zd8jjkgYuzBwDixoAdXmJgT1albrG1Eq4mAeVP39211KZpNY4nusb_QpY_g-4zdhevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxYoY3Ch5VGwf9D0wb9dzp5TtT_UavXl_CPeRGzmCyU-Rw==
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM